At the news
? NEUTRALIMPACT 4/10 8-K filed May 26, 2026 at 09:15 ET
Progyny announced a $200 million share repurchase program, funded from available cash. The program is discretionary with no obligation to repurchase any specific number of shares. This is a capital allocation signal but not a fundamental catalyst.
- Board authorized up to $200 million in common stock repurchases
- Program funded through available cash balances
- Repurchases may be made via open market or Rule 10b5-1 plans
- Program may be suspended or discontinued at any time
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access